BioCentury
ARTICLE | Company News

KineMed, Pfizer deal

April 1, 2013 7:00 AM UTC

The companies extended by one year a 2012 non-exclusive research deal to use KineMed's Dynamic Proteomics technology to evaluate drug candidates on metabolic pathways. KineMed declined to provide deta...